Mining Clinical Data with i2b2


By Maureen McDonough

Aug 15, 2005 | How do you conduct clinical research in the genomic era? A team of Harvard scientists is building an answer from the ground up. A $20-million project, dubbed i2b2 — Informatics for Integrating Biology and the Bedside — will extract information from the private medical files of some 2.5 million people at Boston hospitals in the Partners HealthCare System.

Other research centers are trying to harness their information assets, but Isaac Kohane, one of i2b2’s directors, believes the project is in a unique position to succeed. Partners has invested in IT for two decades — likely the reason i2b2 won the NIH grant — and also has extensive experience in handling ethical concerns surrounding patient information, he says.

Kohane is a believer in clinical data. He points out that there have been no studies comparing the effectiveness of gene expression data and existing clinical data at predicting patient response to various treatments. “The full benefit of either kind of data does not happen until you combine them,” he says.

While microarrays produce vast quantities of data, collecting a comparative amount of clinical information is much more labor intensive. The process of conducting a classic clinical study is both expensive and inefficient because most of the desired data already exists in the patients’ medical records. The i2b2 team is creating a platform that processes information in clinical records and makes it usable in a research context.

Information passes through three steps. After it has been extracted from clinical records, the data must be validated. For example, if researchers want to know a patient’s smoking status, they could call up the patient, compare several clinical documents, or use Bayesian logic algorithms to extract the information from several different patient records. Next the information is organized in a database and finally displayed in a way that the investigator can interpret.

Research centers around the country have specialized in extracting different kinds of information. For example, Columbia University is very good at pulling

information from radiology reports. Recognizing this specialization, the i2b2 team has created what is called a “hive” infrastructure in which many different Web services can be linked together to create workflows. i2b2 has the potential to link research centers around the country so that they can share data-mining tools.

The project has focused on four disease targets including asthma, hypertension, type II diabetes, and Huntington’s disease. Researchers are forming plans to contact asthma patients for a possible clinical study. “What we want to do is turn the medical record world into a clinical research machine,” Kohane says.

The five-year project, which began in the fall of 2004, is an NIH-funded National Center for Biomedical Computing and was established in response to the NIH Roadmap Initiative.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.